FDA Approves Egalet Long-Acting Opioid Painkiller With Abuse-Deterrent Properties

After an independent panel voted for the approval of Egalet Corp's Arymo ER back in August 2016, the FDA released a statement approving the drug. However, the medication does not meet the requirements for claims of deterring snorting.